Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chemokine (C-X-C motif) receptor 3 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0065 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.9331 | 0.9331 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.9331 | 0.8927 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0036 | 0.3765 | 0.5 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0036 | 0.3765 | 0.5 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0037 | 0.4038 | 0.0439 |
Loa Loa (eye worm) | inositol-1 | 0.0036 | 0.3765 | 0.3765 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.9331 | 0.9331 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0036 | 0.3765 | 0.5 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.9331 | 0.8927 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.9331 | 0.8927 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.3765 | 0.3765 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0036 | 0.3765 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.9331 | 0.8927 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0036 | 0.3765 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.9331 | 0.9331 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0037 | 0.4038 | 0.0439 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.9331 | 0.8927 |
Brugia malayi | Inositol-1 | 0.0036 | 0.3765 | 0.3765 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0065 | 1 | 1 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0036 | 0.3765 | 0.5 |
Brugia malayi | RNA binding protein | 0.0062 | 0.9331 | 0.9331 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.3765 | 0.3765 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.3765 | 0.3765 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.9331 | 0.8927 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.9331 | 0.8927 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.3765 | 0.3765 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.9331 | 0.9331 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.9331 | 0.9331 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0032 | 0.2935 | 0.5 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0065 | 1 | 1 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0032 | 0.2935 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.07 uM | Inhibition of CXCL11-stimulated calcium release in HEK293 cells expressing recombinant human CXCR3 and chimeric G protein Gqi5 | ChEMBL. | 16213722 |
IC50 (functional) | = 0.07 uM | Inhibition of CXCL11-stimulated calcium release in HEK293 cells expressing recombinant human CXCR3 and chimeric G protein Gqi5 | ChEMBL. | 16213722 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.